25 March 2021

Unpacking after the trip

For the first time, this Ar Event was available solely online, but that didn’t stop viewers from interacting on all of the available platforms - Zoom, Facebook Live and YouTube - with more than 200 questions shared with our panel of experts.  According to Dr. Bill Richards (who you’ll get to know later!), we are “Moving into new terrain… and we welcome you to join us!”

24 March 2021

The Neuronautas Are Back!

This Gulbenkian Knowledge Academy is looking for young people ready to embark on an intergalactic journey into the future of neuroscience!

In this edition, candidates will be able to choose one of two possible trips - Long Flight (lasting about 4 weeks) or Short Flight (lasting around 2 weeks). For the first, 16 Neurocadets will be recruited and for the second, 8 Chimeras!

10 March 2021

Communicating science: Illustrating how discoveries are made with animated stories

The starting point for the discussion was the “Inside the Unknown” Science Collection, a project developed by this group in collaboration with Champalimaud Research Labs. The genesis of the project, the creative process behind it, the articulation of all the team’s expertises, main challenges and evaluation metrics, were some of the topics addressed in this conversation.

05 March 2021

Champalimaud Foundation’s work with artificial intelligence is the fourth best in the world

Champalimaud Foundation’s work with artificial intelligence is the fourth best in the worldIn the Nature TOP 10, there are institutions from Germany, the United States of America, Portugal, the Netherlands, Spain and the United Kingdom. According to Leonor Beleza, President of the Champalimaud Foundation, “it is a great honour for Portugal and for the Champalimaud Foundation to be at the forefront of scientific research”.

Tripping into the (un)known: treating the mind with psychedelics

For millennia, humans have “tripped” on psychedelic substances for spiritual growth, healing or recreational purposes. Today, the healthcare community has renewed interest in the potential of psychedelics for mental health.

In this Ar event, Tiago Quendera and Tatiana Silva, two neuroscience PhD students at the Champalimaud Centre for the Unknown, will take you through the ups and downs of the history of psychedelics and their use in research.

2021 Champalimaud Research Symposium

CRS21 will focus on the interface of neuroscience, artificial intelligence and machine learning with the main goal of starting an interdisciplinary conversation about the deep conceptual problems that emerge when trying to understand how intelligent behaviour is generated in animals and machines.
 

09 February 2021

Obesity: sensitivity to sweet taste predicts the amount of weight loss that will be induced by stomach surgery to treat obesity

A study led by scientists from the Champalimaud Centre for the Unknown, in Lisbon, concludes that bariatric surgery – that is, procedures used to treat severe obesity by reconfiguring the gastrointestinal tract –, leads to greater weight loss in patients who, before the surgery, had a heightened perception of sweetness.

05 February 2021

Imaging of a living brain can help clearly differentiate between two types of dementia

American actor Robin Williams had a neurodegenerative brain disease called dementia with Lewy bodies (DLB): a distressing disease, with symptoms in common with Alzheimer’s disease (AD) and Parkinson’s disease (PD). But unlike these two conditions, DLB also entails prominent mood and cognitive swings, sleep disorders, and vivid, sometimes terrifying, visual hallucinations.

01 February 2021

Open call for PhD in Neuroscience & Physiology

The INPDP provides students with an integrative, state-of-the-art education in either Neuroscience or Physiology & Cancer. Top evaluated candidates will receive full financial support to participate in classes and conduct research for 5 years with possible extensions.

Subscribe to Neuroscience
Loading
Please wait...